Spruce Biosciences, Inc. (SPRB)
52.70
+1.18
(+2.30%)
USD |
NASDAQ |
May 21, 16:00
51.90
-0.80
(-1.52%)
After-Hours: 19:59
Spruce Biosciences EPS Diluted (Quarterly) : -8.940 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Biogen, Inc. | 2.153 |
| ACADIA Pharmaceuticals, Inc. | 0.0211 |
| Agenus, Inc. | 1.023 |
| Alnylam Pharmaceuticals, Inc. | 1.508 |
| Amgen, Inc. | 3.344 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -12.27M |
| Total Expenses (Quarterly) | 12.27M |
| Enterprise Value | -17.28M |
| Earnings Yield | -71.53% |
| Normalized Earnings Yield | -68.35 |